Articles

Out of Order: Inspired cynic

For a few days, at least, this grumpy old tech has regained a degree of excitement about what is out there and what is possible. It’s a good feeling, and one that I wish for everyone out there.
Written byRandall C Willis
| 3 min read

I am a cynical old man, but I came by it honestly. Perhapsit started with the decade of academic research, where failure was not just anoption, but also a constant reality that was only punctuated by moments ofclarity. Perhaps it came from all my years as a science writer, working inpublishing or advertising. Heck, I started my writing career with a columncalled "The Grumpy Old Tech," and I was only in my 30s.

As with all but our youngest readers, I have watchedtechnologies and insights cycle several times over the span of a coupledecades. Success in a test tube is immediately hailed as a paradigm-shiftingbreakthrough that will lead to cures for cancer, diabetes, heart disease, goutand hiccups. When the genome hits $1,000 we shall join hands and enter Elysium(not the movie).

To continue reading this article, subscribe for FREE toDrug Discovery News Logo

Subscribe today to keep up to date with the latest advancements and discoveries in drug development achieved by scientists in pharma, biotech, non-profit, academic, clinical, and government labs.

Add Drug Discovery News as a preferred source on Google

Add Drug Discovery News as a preferred Google source to see more of our trusted coverage.

About the Author

Here are some related topics that may interest you:

Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

3D illustration of a single cell surrounded by small molecular particles in a red biological environment.
Measuring mRNA and protein together at single cell resolution can uncover tumor-specific signaling activity and immune features.
Illustration of an antibody intertwined with a DNA double helix.
Discover how CRISPR and single-cell RNA sequencing can connect disease-associated variants to regulatory elements, genes, and pathways.
Digital illustration of the human digestive system highlighting the liver, stomach, and intestines.
Explore how human gut-liver models can improve the translation of preclinical findings into clinical pharmacokinetic predictions.